Importantly, macrophages were engineered with mono-TRAIL and Tri-TRAIL, and the results revealed that Tri-TRAIL demonstrated higher cytotoxic effects against tumor cells as compared to Mono-TRAIL. The gene discussed is TNFSF10; the disease is neoplasm.